Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute

Professor of Genetics and Medicine, Harvard Medical School

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute

Dana Farber Cancer Institute

617-632-4377

Meyerson Lab

Publications

ROS1 rearrangements in lung cancer: a new genomic subset of lung adenocarcinoma.

Authors: Authors: Jänne PA, Meyerson M.
J Clin Oncol 2012-03-10
View full abstract on Pubmed

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors: Authors: Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M.
Genome Res 2012-02-01
View full abstract on Pubmed

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.

Authors: Authors: Wagle N, Berger MF, Davis MJ, Blumenstiel B, Defelice M, Pochanard P, Ducar M, Van Hummelen P, Macconaill LE, Hahn WC, Meyerson M, Gabriel SB, Garraway LA.
Cancer Discov 2012-01-01
View full abstract on Pubmed

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors: Authors: Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, Hacohen N, Reed R, Meyerson M, Golub TR, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ.
N Engl J Med 2011-12-29
View full abstract on Pubmed

Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.

Authors: Authors: Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, Dutt A, Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, Kesari S, Meyerson M.
Cancer Res 2011-12-15
View full abstract on Pubmed

Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.

Authors: Authors: Cheung HW, Du J, Boehm JS, He F, Weir BA, Wang X, Butaney M, Sequist LV, Luo B, Engelman JA, Root DE, Meyerson M, Golub TR, Jänne PA, Hahn WC.
Cancer Discov 2011-12-01
View full abstract on Pubmed

High order chromatin architecture shapes the landscape of chromosomal alterations in cancer.

Authors: Authors: Fudenberg G, Getz G, Meyerson M, Mirny LA.
Nat Biotechnol 2011-11-20
View full abstract on Pubmed

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.

Authors: Authors: Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, Cibulskis K, Sougnez C, Voet D, Saksena G, Sivachenko A, Jing R, Parkin M, Pugh T, Verhaak RG, Stransky N, Boutin AT, Barretina J, Solit DB, Vakiani E, Shao W, Mishina Y, Warmuth M, Jimenez J, Chiang DY, Signoretti S, Kaelin WG, Spardy N, Hahn WC, Hoshida Y, Ogino S, DePinho RA, Chin L, Garraway LA, Fuchs CS, Baselga J, Tabernero J, Gabriel S, Lander ES, Getz G, Meyerson M.
Nat Genet 2011-09-04
View full abstract on Pubmed

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges.

Authors: Authors: MacConaill LE, Van Hummelen P, Meyerson M, Hahn WC.
Cancer Discov 2011-09-01
View full abstract on Pubmed

The mutational landscape of head and neck squamous cell carcinoma.

Authors: Authors: Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortés ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR.
Science 2011-08-26
View full abstract on Pubmed